Vivozon Montelukast Chewable Tablet 4mg (Montelukast Sodium)

Adult dose

This medication is taken once daily. For asthma patients, it should be taken in the evening. For allergic rhinitis patients, the timing of the dose is determined based on the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet in the evening once daily. This medication should be administered 1 hour before meals or 2 hours after meals.

Child dose

Children aged 2 to 5 years should chew 4 mg once daily as montelukast. This medication should be administered 1 hour before meals or 2 hours after meals.

This medication may cause significant neuropsychiatric symptoms; therefore, if you experience mental changes such as anxiety, depression, agitation, or suicidal thoughts during treatment, consult your doctor immediately. This medication contains aspartame, an artificial sweetener, and should be avoided by patients with phenylketonuria, a hereditary disease. Patients with hypersensitivity to this medication or its components should not use it. For asthma patients, this medication is not intended for the treatment of acute asthma attacks, so always carry a rescue inhaler. Do not abruptly discontinue inhaled corticosteroids or switch to this medication without following your doctor's guidance on tapering. Patients who have a hypersensitivity reaction to aspirin should avoid taking aspirin or non-steroidal anti-inflammatory drugs during treatment with this medication. If they must take them, they should consult their doctor first. During treatment with this medication, symptoms related to eosinophilia and worsening pulmonary symptoms may arise, so if these symptoms occur, seek medical attention immediately. No special drug interaction reports have been noted when taken with other medications; however, caution may be needed when used with certain hepatic enzyme inducers, so inform your doctor. If pregnant or breastfeeding, use this medication only when necessary, and consult your doctor before taking it. Safety and efficacy have also been confirmed in pediatric patients, but it is recommended to avoid use in infants under 6 months old. There is no specific antidote for overdose, so immediate medical assistance should be sought for general treatment and observation. This medication is sensitive to light; therefore, do not open the package until just before use, and consume it immediately after opening. Keep this medication out of the reach of children and do not transfer it to another container. Adhere to the prescribed dosage and regimen, and consult your doctor if symptoms worsen or new symptoms appear.

Serious side effects

Urticaria, angioedema, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, very rare anaphylaxis (serious allergic reaction), severe skin adverse reactions (toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme, nodular erythema), respiratory issues (eosinophilic pneumonitis, asthma attack, wheezing), hepatic abnormalities (increased ALT and AST, cholestatic hepatitis, hepatocellular liver damage, mixed-type liver dysfunction)

Mild side effects

• Dizziness
• headache
• weakness/fatigue
• fever
• abdominal pain
• dyspepsia
• infectious gastroenteritis
• toothache
• nasal congestion
• cough

This medication is sensitive to moisture and light, so store it at room temperature between 1 to 30 degrees Celsius. It is also important to keep it in a tightly closed container to prevent air from entering.

Appearance

Pink oval chewable tablet

Package unit

28 tablets/PTP [7 tablets/PTP X 4]